Open access · OA
via OpenAlex
Alpha-synuclein and familial Parkinson's disease
Proceedings for Annual Meeting of The Japanese Pharmacological Society · 2018
Abstract
SNCA multiplication is a cause for familial Parkinson's disease (PD). We have identified several families with SNCA multiplication. Molecular characterization was performed using real-time PCR, SNP arrays, and haplotype analysis. We further studied those patients who were found to harbor SNCA duplication with olfactory function tests, polysomnography, and PET. We identified six families and one sporadic patient with SNCA duplication, and one family with SNCA triplication, respectively. The lifetime estimate of overall penetrance was ca. 40%. FDG-PET study of symptomatic patients showed hypometabolism in the occipital lobe, whereas asymptomatic carriers of SNCA duplication demonstrated normal glucose metabolism. Symptomatic patients showed abnormal olfactory function and polysomnography and asymptomatic carriers showed normal results. The clinical features of SNCA duplication include parkinsonism with or without dementia. Asymptomatic carriers displayed normal test results with the eldest individual aged 79 years; thus, even a carrier of SNCA duplication may escape the development of PD. This difference in age-associated penetrance may be due to the genetic background or environmental exposures. Further studies of SNCA multiplication carriers will help identify disease-modifiers and may open novel avenues for future treatment. IN addition to SNCA multiplication, we have identified homozygous A53V mutation. This is the first homozygous missense mutation. Clinical features revealed mild phenotypes even though the presence two allele mutations. In this symposium, I will discuss the relationship between clinical phenotypes and genotypes including gene dosage.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1254/jpssuppl.wcp2018.0_sy54-1
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Hattori, N. (2018). Alpha-synuclein and familial Parkinson's disease. <em>Proceedings for Annual Meeting of The Japanese Pharmacological Society</em>. https://doi.org/10.1254/jpssuppl.wcp2018.0_sy54-1
Vancouver
Hattori N. Alpha-synuclein and familial Parkinson's disease. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2018. doi:10.1254/jpssuppl.wcp2018.0_sy54-1.
BibTeX
@article{nobutaka2018Alphas,
title = {Alpha-synuclein and familial Parkinson's disease},
author = {Nobutaka Hattori},
journal = {Proceedings for Annual Meeting of The Japanese Pharmacological Society},
year = {2018},
doi = {10.1254/jpssuppl.wcp2018.0_sy54-1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Istituto Auxologico Italiano 2023
Open access · US-GOV
Gait and Balance Impairment in Rare and Very Rare Neurological Diseases
Life 2021
Open access · CC-BY
The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
Konya Beyhekim Training and Research Hospital 2023
Open access · US-GOV
The Frequency of Osteosarcopenia in Patients With Rheumatoid Arthritis and the Factors Affecting the Sarcopenia-osteoporosis Relationship
European Journal of Neurology 2003
Citation only
Clinical characteristics of the alpha‐synuclein mutation (G209A)‐associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece
cIRcle (University of British Columbia) 2017
Preprint · CC-BY
Selective neurodegeneration in Alzheimer's disease and Parkinson's disease
Movement Disorders 2013
Citation only